Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Agfa-Gevaert NV    AGFB   BE0003755692

AGFA-GEVAERT NV

(AGFB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company usually posts poor financials for mid or long term investments.
Strengths
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.37 for the 2020 fiscal year.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 3.54 EUR
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at EUR 4.03.
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
AGFA-GEVAERT NV1.79%811
THERMO FISHER SCIENTIFIC10.00%203 954
DANAHER CORPORATION7.16%169 098
SHENZHEN MINDRAY BIO-MEDICA..12.25%89 689
INTUITIVE SURGICAL, INC.-9.05%87 471
ILLUMINA, INC.9.80%59 313
SIEMENS HEALTHINEERS AG6.55%58 301
EDWARDS LIFESCIENCES CORPOR..-6.26%53 300
BOSTON SCIENTIFIC CORPORATI..3.00%53 024
KONINKLIJKE PHILIPS N.V.4.24%50 522
AGILENT TECHNOLOGIES, INC.6.62%38 764
RESMED, INC.2.12%31 232
OLYMPUS CORPORATION-6.91%26 018
CERNER CORPORATION1.81%24 497
HOLOGIC, INC.3.94%19 505
PERKINELMER, INC.5.86%17 010
More Results
Financials
Sales 2020 1 718 M 2 090 M 2 090 M
Net income 2020 636 M 774 M 774 M
Net cash 2020 22,1 M 26,9 M 26,9 M
P/E ratio 2020 1,05x
Yield 2020 -
Capitalization 666 M 811 M 810 M
EV / Sales 2020 0,37x
EV / Sales 2021 0,37x
Nbr of Employees 9 571
Free-Float 97,6%
Upcoming event on AGFA-GEVAERT NV
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating -
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability -
Earnings quality
Business Predictability -
P/E ratio -
Potential
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes